Covaxin For 2-18

Covid-19 Vaccine: Covaxin Recommended By Expert Panel For 2-18 Years

NDTV

Coronavirus Vaccine | Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report

NDTV

Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech

The Economic Times

Covaxin clinical trials for children (2 – 18 years) approved by DCGI

The Hindu businessline

Covid Vaccine: Covaxin Approved For Kids Aged 2-18 Years | Breaking News

Covaxin gets nod for phase 2/3 trials on 2-18 year-olds: Why it is significant

Hindustan Times

Covid Vaccine For Kids: Covaxin Approved For Children In 2-18 Age Group | Covid 360

Covaxin gets emergency use approval for children aged 2-18 years

Covaxin Approved For Kids In 2-18 Age Groups, Dr Rahul Pandit Speaks To India Today

Covaxin Gets Emergency Use Approval For Kids Aged 2-18 Years | Breaking News

Bharat Biotech will begin clinical trial of Covaxin on 2-18 age group

Headlines: Covaxin Gets EUA From India's Drugs Controller For 2-18 Years Age Kids | Covid Vaccine

HW News English

What Parents' Say Over Covaxin Gets Approval For Kids Aged 2-18 Years | Reporter Diary

Headlines: Expert Panel Recommends Covaxin Trial On Children Aged 2-18 Years

HW News English

Parents' Reaction As Covaxin Gets Approval For Kids Aged 2-18 Years | Reporter Diary

Expert Panel Approves Covaxin Phase 2& 3 Trials For Children Between 2-18 Years

Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group

Covid Vaccine For Kids ! Expert Panel Approves Covaxin For Kids Aged 2-18 Years | Breaking News

DCGI Approves Covaxin Clinical Trial On 2-18 Year Age Group | OTV News

OTV News English

Covaxin for kids: Vaccine one step away from use in India for 2-18 age group after expert panel nod

Hindustan Times